Objective:

To discuss the latest surgical and nonsurgical approaches to treating presbyopia, emphasizing the critical role of patient selection and expectation management in achieving optimal outcomes.

Approach:

Key Findings:

• Presbyopia affects nearly 130 million Americans and typically begins in the early to mid-40s.
• Different refractive errors and patient goals significantly influence treatment options, necessitating a tailored approach.
• Innovative intraocular lens technologies, such as multifocal and extended depth of focus lenses, are available but come with risks, including potential retinal complications.

Interpretation:

Effective management of presbyopia requires a comprehensive understanding of individual patient needs, refractive errors, and age-related factors to tailor treatment options appropriately.

Limitations:

• Some treatments, like phakic IOLs, are considered off-label for patients over 45, which can complicate treatment decisions.
• Many presbyopia drops are not FDA approved and cannot be offered yet, limiting options for patients.
• Adaptation to multifocal lenses varies among patients, and some may require additional procedures, highlighting the need for careful patient selection.

Conclusion:

A comprehensive understanding of patient expectations and the limitations of available technologies is crucial for successful presbyopia treatment, ensuring that patients are well-informed and prepared for their options.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.